Jacquelynn M Dimuccio, PA-C | |
1150 Reservoir Ave Ste 203, Cranston, RI 02920-6043 | |
(401) 259-0340 | |
Not Available |
Full Name | Jacquelynn M Dimuccio |
---|---|
Gender | Female |
Speciality | Physician Assistant |
Location | 1150 Reservoir Ave Ste 203, Cranston, Rhode Island |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1275155574 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363A00000X | Physician Assistant | PA01239 (Rhode Island) | Primary |
Mailing Address | Practice Location Address |
---|---|
Jacquelynn M Dimuccio, PA-C 1150 Reservoir Ave Ste 203, Cranston, RI 02920-6043 Ph: (401) 259-0340 | Jacquelynn M Dimuccio, PA-C 1150 Reservoir Ave Ste 203, Cranston, RI 02920-6043 Ph: (401) 259-0340 |
News Archive
PeriGen, Inc., the only OB-specific risk reduction company to provide solutions which generate immediate quantifiable clinical and financial value, today announced the formation of a strategic alliance with Willis Group Holdings, a leading global insurance broker and one of the world's largest professional services firms specializing in risk management.
New guidance is available for physicians who must go through a number of steps to provide a probable diagnosis of sarcoidosis - an inflammatory disease that affects the lungs, lymph glands, and other organs.
iCAD, Inc., an industry-leading provider of advanced image analysis and workflow solutions for the early identification of cancer, today announces a strategic partnership with the AdMeTech Foundation, a non-profit organization with a mission to end prostate cancer as a patient care crisis and socio-economic problem.
Results from the VeriStrat biomarker analysis of a multicenter Phase III trial were presented today at the 2nd European Lung Cancer Conference currently being held in Geneva, Switzerland. Results showed that the VeriStrat test identified patients who were likely to have a survival benefit from treatment with erlotinib, a commonly prescribed oral therapy for advanced non-small cell lung cancer.
A diverse team of scientists from UCLA's Jonsson Comprehensive Cancer Center have developed an experimental treatment that eradicates an acute type of leukemia in mice without any detectable toxic side effects. The drug works by blocking two important metabolic pathways that the leukemia cells need to grow and spread.
› Verified 5 days ago
Brianna Southwick, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 333 Budlong Rd, Cranston, RI 02920 Phone: 401-943-4530 | |
Leanne M Nadeau, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 333 Budlong Rd, Cranston, RI 02920 Phone: 401-943-4530 Fax: 401-943-5107 | |
Kathleen Ricci, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 75 Sockanosset Cross Rd Ste 100, Cranston, RI 02920 Phone: 401-946-6200 Fax: 401-275-1992 | |
Grace Barber, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 2000 Chapel View Blvd, Suite 225, Cranston, RI 02920 Phone: 401-400-8414 | |
Mrs. Jennifer Lynn Geremia, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1150 Reservoir Avenue, Suite 201, Cranston, RI 02920 Phone: 401-943-1300 Fax: 401-946-8480 | |
Sophia Grace Brownstein, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1150 Reservoir Ave Ste 300, Cranston, RI 02920 Phone: 401-223-2828 | |
Susan Pitt, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 75 Sockanosset Cross Rd, Cranston, RI 02920 Phone: 401-946-6200 Fax: 401-275-1992 |